Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 3
1997 1
1998 2
1999 2
2000 1
2002 1
2003 2
2004 1
2007 2
2010 1
2011 1
2012 1
2013 2
2014 1
2015 1
2017 2
2018 2
2019 3
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey.
Rossato P, Glantschnig H, Leidenmühler P, Kopic A, Ruthsatz T, Majer B, Schuster M, Scheiflinger F, Höllriegl W. Rossato P, et al. Among authors: glantschnig h. Blood Coagul Fibrinolysis. 2022 Jan 1;33(1):56-60. doi: 10.1097/MBC.0000000000001064. Blood Coagul Fibrinolysis. 2022. PMID: 34267062 Free PMC article.
Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
Rossato P, Federti E, Matte A, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Andolfo I, Iolascon A, Rottensteiner H, Gritsch H, Scheiflinger F, Hoellriegl W, Franceschi L. Rossato P, et al. Among authors: glantschnig h. Haematologica. 2022 Nov 1;107(11):2650-2660. doi: 10.3324/haematol.2021.280233. Haematologica. 2022. PMID: 35443560 Free PMC article.
Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
Rossato P, Glantschnig H, Canneva F, Schuster M, Coulibaly S, Schrenk G, Voelkel D, Dockal M, Plaimauer B, Rottensteiner H, Gritsch H, Federti E, Matte A, De Franceschi L, Scheiflinger F, Hoellriegl W. Rossato P, et al. Among authors: glantschnig h. J Thromb Haemost. 2023 Feb;21(2):269-275. doi: 10.1016/j.jtha.2022.10.016. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36700507 Free article.
Coagulation phenotype of wild-type mice on different genetic backgrounds.
Kopić A, Benamara K, Schuster M, Leidenmühler P, Bauer A, Glantschnig H, Höllriegl W. Kopić A, et al. Among authors: glantschnig h. Lab Anim. 2019 Feb;53(1):43-52. doi: 10.1177/0023677218811059. Epub 2018 Nov 12. Lab Anim. 2019. PMID: 30419767 Free PMC article.
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys.
Glantschnig H, Bauer A, Benamara K, Dockal M, Ehrlich V, Gritsch H, Höbarth G, Horling FM, Kopic A, Leidenmühler P, Reipert BM, Rottensteiner H, Ruthsatz T, Schrenk G, Schuster M, Turecek PL, Weber A, Wolfsegger M, Scheiflinger F, Höllriegl W. Glantschnig H, et al. J Pharmacol Exp Ther. 2019 Oct;371(1):95-105. doi: 10.1124/jpet.119.260067. Epub 2019 Jul 31. J Pharmacol Exp Ther. 2019. PMID: 31366602
Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.
Chiu CS, Peekhaus N, Weber H, Adamski S, Murray EM, Zhang HZ, Zhao JZ, Ernst R, Lineberger J, Huang L, Hampton R, Arnold BA, Vitelli S, Hamuro L, Wang WR, Wei N, Dillon GM, Miao J, Alves SE, Glantschnig H, Wang F, Wilkinson HA. Chiu CS, et al. Among authors: glantschnig h. J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1181-92. doi: 10.1093/gerona/glt030. Epub 2013 Mar 22. J Gerontol A Biol Sci Med Sci. 2013. PMID: 23525481
31 results